Filing metadata

Accession number
0001062993-20-001281
Form type
Form 3
Filer
NRX Pharmaceuticals, Inc.
CIK
CIK 1719406
Filed
Mar 06, 2020
Reporting period
Feb 27, 2020
Description
Initial ownership

Explore SEC Filings Hub